Premium
Genetic association of two chromosome 14 genes (presenilin 1 and α 1 ‐Antichymotrypsin) with Alzheimer's disease
Author(s) -
Wang Xiaoyan,
DeKosky Steven T.,
Wisniewski Stephen,
Aston Christopher E.,
Kamboh M. Ilyas
Publication year - 1998
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.410440316
Subject(s) - haplotype , allele , presenilin , genetics , genotype , alzheimer's disease , disease , biology , genetic association , gene , degenerative disease , allele frequency , chromosome , chromosome 17 (human) , single nucleotide polymorphism , medicine
We have investigated the association of two candidate genes on chromosome 14, presenilin 1 (PS1) and α 1 ‐antichymotrypsin (ACT), with the risk of sporadic Alzheimer's disease (AD) by using 427 AD cases and 250 controls. The frequency of the ACT * A allele was significantly higher in cases than controls (0.550 vs 0.466). The stratification of the ACT data by PS1 genotypes showed that the risk associated with the ACT * A allele was confined to PS1 * 1 carriers only. The two‐site haplotype data for PS1 and ACT showed that the A1 haplotype, carrying the ACT * A and PS1 * 1 alleles, was more frequent in cases then controls (0.310 vs 0.251), whereas the frequency of the T2 haplotype, carrying the ACT * T and PS1 * 2 alleles, was lower in cases than controls (0.177 vs 0.237). These data indicate a possible synergistic effect of these two loci on the risk of AD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom